SCHEMBL23453049

SCHEMBL23453049

CCOC(=O)CN(CCNC(=O)OC(C)(C)C)C(=O)Cn1cnc2c(NCC(=O)OCc3ccccc3)ncnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
TMIGD3 P0DMS9 4/20 0.39
ADORA2A P29274 4/20 0.39
ADORA1 P30542 4/20 0.39
ADORA2B P29275 1/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HTT P42858 2/20 0.38
CCNE2 O96020 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
GALR3 O60755 1/20 0.36
NR2F2 P24468 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23453059 0.97 TDP1 (0.41) TDP1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL23453050 0.94 TDP1 (0.40) TDP1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL23453058 0.92 HDAC1 (0.41) TDP1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL23453066 0.87 TDP1 (0.43) TDP1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL6803680 0.85 TDP1 (0.40) TDP1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL7263078 0.84 HDAC1 (0.41) TDP1HDAC1HDAC2CCNE2CCNE1
SCHEMBL17739752 0.83 GALR3 (0.40) CCNE2CCNE1CDK2MEN1KMT2A
SCHEMBL23453045 0.83 PDE4A (0.38) TDP1TMIGD3ADORA2AADORA1HDAC1
SCHEMBL432254 0.82 CCNE2 (0.40) HDAC1HDAC2CCNE2CCNE1CDK2
SCHEMBL10047121 0.80 HDAC1 (0.39) TMIGD3ADORA2AADORA1HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163541-A1 Method for Preparing PNA Oligomer SEASUNBIO MATERIALS (KR) 2021-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163541-A1 Method for Preparing PNA Oligomer NCL, NOD1, POLI TDP1 775/4885TMIGD3 3949/4885ADORA2A 4157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.